Skip to main content

Table 1 The outstanding disease-free prognostic genes for colon cancer

From: Independent prognostic genes and mechanism investigation for colon cancer

Gene

FC

P

GSE17536

GSE39582

Log-rank P

HR

95% CI

Log-rank P

HR

95% CI

SFTA2

63.45

1.6E−91

8.87E−03

0.488

0.49 (0.28–0.84)

2.29E−02

0.708

0.71 (0.53–0.95)

LEMD1

32.47

4.3E−98

1.32E−02

0.506

0.51 (0.29–0.88)

1.47E−02

0.692

0.69 (0.51–0.93)

COMP

14.33

4.3E−82

3.70E−03

0.444

0.44 (0.25–0.78)

1.48E−02

0.691

0.69 (0.51–0.93)

KIF26B

6.86

2.4E−64

5.85E−03

0.466

0.47 (0.27–0.81)

1.09E−02

0.679

0.68 (0.5–0.92)

KLK10

6.06

1.1E−99

5.28E−03

0.462

0.46 (0.26–0.81)

7.06E−03

0.666

0.67 (0.49–0.9)

MMP11

3.74

6.8E−127

2.96E−03

0.44

0.44 (0.25–0.77)

3.68E−02

0.731

0.73 (0.54–0.98)

GRP

3.22

2.4E−15

1.43E−02

0.515

0.52 (0.3–0.88)

1.16E−04

0.554

0.55 (0.41–0.75)

TWIST1

2.59

1.3E−28

4.07E−02

0.562

0.56 (0.32–0.98)

4.29E−02

0.736

0.74 (0.55–0.99)

RGS16

2.29

2.1E−25

1.90E−04

0.346

0.35 (0.19–0.62)

3.48E−02

0.726

0.73 (0.54–0.98)

COL8A1

2.01

9.6E−15

1.68E−04

0.338

0.34 (0.19–0.61)

6.21E−03

0.661

0.66 (0.49–0.89)

TMEM37

0.47

1.3E−23

1.41E−02

1.986

1.99 (1.14–3.47)

1.28E−02

1.457

1.46 (1.08–1.96)

ARHGAP44

0.45

4.8E−20

4.88E−02

1.717

1.72 (1–2.96)

4.58E−02

1.349

1.35 (1–1.82)

  1. FC fold change, HR hazard ratio, CI confidence interval
  2. P < 0.05 was considered as significant different